AAAAAA

   
Results: 1-21 |
Results: 21
SERUM AND CYSTIC FLUID LEVELS OF SOLUBLE INTERLEUKIN-2 RECEPTOR-ALPHAIN PATIENTS WITH EPITHELIAL OVARIAN-TUMORS ARE CORRELATED
Authors: DEBRUIJN HWA TENHOOR KA VANDERZEE AGJ
Citation: Hwa. Debruijn et al., SERUM AND CYSTIC FLUID LEVELS OF SOLUBLE INTERLEUKIN-2 RECEPTOR-ALPHAIN PATIENTS WITH EPITHELIAL OVARIAN-TUMORS ARE CORRELATED, Tumor biology, 19(3), 1998, pp. 160-166
IS OVARIAN-CYST FORMATION RELATED TO TAMOXIFEN USE
Authors: MOURITS MJE DEVRIES EGE WILLEMSE PHB TENHOOR KA HOLLEMA H DEBRUIJN HWA VANDERZEE HWA
Citation: Mje. Mourits et al., IS OVARIAN-CYST FORMATION RELATED TO TAMOXIFEN USE, European journal of cancer, 34, 1998, pp. 21-22
THE VALUE OF CANCER ANTIGEN-125 (CA-125) DURING TREATMENT AND FOLLOW-UP OF PATIENTS WITH OVARIAN-CANCER
Authors: DEBRUIJN HWA VANDERZEE AGJ AALDERS JG
Citation: Hwa. Debruijn et al., THE VALUE OF CANCER ANTIGEN-125 (CA-125) DURING TREATMENT AND FOLLOW-UP OF PATIENTS WITH OVARIAN-CANCER, Current opinion in obstetrics & gynecology, 9(1), 1997, pp. 8-13
QUANTIFICATION OF VASCULAR DENSITY AND OF LUMEN AND VESSEL MORPHOLOGYIN ENDOMETRIAL CARCINOMA - EVALUATION OF THEIR RELATION TO SERUM LEVELS OF TISSUE POLYPEPTIDE-SPECIFIC ANTIGEN AND CA-125
Authors: WILLEMSE F NAP M DEBRUIJN HWA HOLLEMA H
Citation: F. Willemse et al., QUANTIFICATION OF VASCULAR DENSITY AND OF LUMEN AND VESSEL MORPHOLOGYIN ENDOMETRIAL CARCINOMA - EVALUATION OF THEIR RELATION TO SERUM LEVELS OF TISSUE POLYPEPTIDE-SPECIFIC ANTIGEN AND CA-125, Analytical and quantitative cytology and histology, 19(1), 1997, pp. 1-7
RELATION BETWEEN HPV-16 SEROLOGY AND CLINICOPATHOLOGICAL DATA IN CERVICAL-CARCINOMA PATIENTS - PROGNOSTIC VALUE OF ANTI-E6 AND OR ANTI-E7 ANTIBODIES/
Authors: BAAY MFD DUK JM GROENIER KH BURGER MPM DEBRUIJN HWA HOLLEMA H STOLZ E HERBRINK P
Citation: Mfd. Baay et al., RELATION BETWEEN HPV-16 SEROLOGY AND CLINICOPATHOLOGICAL DATA IN CERVICAL-CARCINOMA PATIENTS - PROGNOSTIC VALUE OF ANTI-E6 AND OR ANTI-E7 ANTIBODIES/, Cancer immunology and immunotherapy, 44(4), 1997, pp. 211-215
EFFECT OF LOW-DOSE ORAL ETOPOSIDE ON SERUM CA-125 IN PATIENTS WITH ADVANCED EPITHELIAL OVARIAN-CANCER
Authors: DEJONG RS HOFSTRA LS WILLEMSE PHB DEBRUIJN HWA DEVRIES EGE BOONSTRA H MULDER NH
Citation: Rs. Dejong et al., EFFECT OF LOW-DOSE ORAL ETOPOSIDE ON SERUM CA-125 IN PATIENTS WITH ADVANCED EPITHELIAL OVARIAN-CANCER, Gynecologic oncology, 66(2), 1997, pp. 197-201
RISING SERUM VALUES OF BETA-SUBUNIT HUMAN CHORIONIC-GONADOTROPIN (HCG) IN PATIENTS WITH PROGRESSIVE VULVAR CARCINOMAS
Authors: DEBRUIJN HWA TENHOOR KA KRANS M VANDERZEE AGJ
Citation: Hwa. Debruijn et al., RISING SERUM VALUES OF BETA-SUBUNIT HUMAN CHORIONIC-GONADOTROPIN (HCG) IN PATIENTS WITH PROGRESSIVE VULVAR CARCINOMAS, British Journal of Cancer, 75(8), 1997, pp. 1217-1218
RAISED SERUM SQUAMOUS-CELL CARCINOMA ANTIGEN LEVELS IN MALIGNANT TRANSFORMATION OF MATURE CYSTIC OVARIAN TERATOMA
Authors: DEBRUIJN HWA HOLLEMA H WILLEMSE PHB TENHOOR KA BOONSTRA H
Citation: Hwa. Debruijn et al., RAISED SERUM SQUAMOUS-CELL CARCINOMA ANTIGEN LEVELS IN MALIGNANT TRANSFORMATION OF MATURE CYSTIC OVARIAN TERATOMA, International journal of gynecological cancer, 6(1), 1996, pp. 76-79
IMMUNOHISTOCHEMICAL CHARACTERIZATION OF 22 MONOCLONAL-ANTIBODIES AGAINST THE CA125 ANTIGEN - 2ND REPORT FROM THE ISOBM TD-1 WORKSHOP
Authors: NAP M VITALI A NUSTAD K BAST RC OBRIEN TJ NILSSON O SEGUIN P SURESH MR BORMER OP SAGA T DEBRUIJN HWA NOZAWA S KREUTZ FT JETTE D SAKAHARA H GADNELL M ENDO K BARLOW EH WARREN D PAUS E HAMMARSTROM S KENEMANS P HILGERS J
Citation: M. Nap et al., IMMUNOHISTOCHEMICAL CHARACTERIZATION OF 22 MONOCLONAL-ANTIBODIES AGAINST THE CA125 ANTIGEN - 2ND REPORT FROM THE ISOBM TD-1 WORKSHOP, Tumor biology, 17(6), 1996, pp. 325-331
SPECIFICITY AND AFFINITY OF 26 MONOCLONAL-ANTIBODIES AGAINST THE CA-125 ANTIGEN - FIRST REPORT FROM THE ISOBM TD-1 WORKSHOP
Authors: NUSTAD K BAST RC OBRIEN TJ NILSSON O SEGUIN P SURESH MR SAGA T NOZAWA S BORMER OP DEBRUIJN HWA NAP M VITALI A GADNELL M CLARK J SHIGEMASA K KARLSSON B KREUTZ FT JETTE D SAKAHARA H ENDO K PAUS E WARREN D HAMMARSTROM S KENEMANS P HILGERS J
Citation: K. Nustad et al., SPECIFICITY AND AFFINITY OF 26 MONOCLONAL-ANTIBODIES AGAINST THE CA-125 ANTIGEN - FIRST REPORT FROM THE ISOBM TD-1 WORKSHOP, Tumor biology, 17(4), 1996, pp. 196-219
CONCURRENT CHEMOTHERAPY AND RADIOTHERAPY IN PATIENTS WITH LOCALLY ADVANCED-CARCINOMA OF THE CERVIX
Authors: PRAS E WILLEMSE PHB BOONSTRA H HOLLEMA H HEESTERS MAAM SZABO BG DEBRUIJN HWA AALDERS JG DEVRIES EGE
Citation: E. Pras et al., CONCURRENT CHEMOTHERAPY AND RADIOTHERAPY IN PATIENTS WITH LOCALLY ADVANCED-CARCINOMA OF THE CERVIX, Annals of oncology, 7(5), 1996, pp. 511-516
PRETREATMENT SERUM SQUAMOUS-CELL CARCINOMA ANTIGEN - A NEWLY IDENTIFIED PROGNOSTIC FACTOR IN EARLY-STAGE CERVICAL-CARCINOMA
Authors: DUK JM GROENIER KH DEBRUIJN HWA HOLLEMA H TENHOOR KA VANDERZEE AGJ AALDERS JG
Citation: Jm. Duk et al., PRETREATMENT SERUM SQUAMOUS-CELL CARCINOMA ANTIGEN - A NEWLY IDENTIFIED PROGNOSTIC FACTOR IN EARLY-STAGE CERVICAL-CARCINOMA, Journal of clinical oncology, 14(1), 1996, pp. 111-118
DETECTION OF RECURRENCE IN PATIENTS WITH CLINICAL STAGE-I NONSEMINOMATOUS TESTICULAR GERM-CELL TUMORS AND CONSEQUENCES FOR FURTHER FOLLOW-UP - A SINGLE-CENTER 1O-YEAR EXPERIENCE
Authors: GELS ME HOEKSTRA HJ SLEIJFER DT MARRINK J DEBRUIJN HWA MOLENAAR WM FRELING NJM DROSTE JHJ KOOPS HS
Citation: Me. Gels et al., DETECTION OF RECURRENCE IN PATIENTS WITH CLINICAL STAGE-I NONSEMINOMATOUS TESTICULAR GERM-CELL TUMORS AND CONSEQUENCES FOR FURTHER FOLLOW-UP - A SINGLE-CENTER 1O-YEAR EXPERIENCE, Journal of clinical oncology, 13(5), 1995, pp. 1188-1194
CONCANAVALIN-A VARIANTS OF ALPHA-FETOPROTEIN IN FIRST TRIMESTER FETUSES WITH TRISOMY-21 AND WITH NORMAL KARYOTYPES
Authors: LOS FJ JANSE HC BRANDENBURG H DEVRIJ RW DEBRUIJN HWA
Citation: Fj. Los et al., CONCANAVALIN-A VARIANTS OF ALPHA-FETOPROTEIN IN FIRST TRIMESTER FETUSES WITH TRISOMY-21 AND WITH NORMAL KARYOTYPES, Gynecologic and obstetric investigation, 39(3), 1995, pp. 149-152
FOLLOW-UP OF ANTIBODY-RESPONSES TO HUMAN PAPILLOMAVIRUS TYPE-16 E7 INPATIENTS TREATED FOR CERVICAL-CARCINOMA
Authors: BAAY MFD DUK JM BURGER MPM DEBRUIJN HWA STOLZ E HERBRINK P
Citation: Mfd. Baay et al., FOLLOW-UP OF ANTIBODY-RESPONSES TO HUMAN PAPILLOMAVIRUS TYPE-16 E7 INPATIENTS TREATED FOR CERVICAL-CARCINOMA, Journal of medical virology, 45(3), 1995, pp. 342-347
CELL BIOLOGICAL MARKERS OF DRUG-RESISTANCE IN OVARIAN-CARCINOMA
Authors: VANDERZEE AGJ HOLLEMA HH DEBRUIJN HWA WILLEMSE PHB BOONSTRA H MULDER NH AALDERS JG DEVRIES EGE
Citation: Agj. Vanderzee et al., CELL BIOLOGICAL MARKERS OF DRUG-RESISTANCE IN OVARIAN-CARCINOMA, Gynecologic oncology, 58(2), 1995, pp. 165-178
ANTIBODIES TO HUMAN PAPILLOMAVIRUS TYPE-16 E7 RELATED TO CLINICOPATHOLOGICAL DATA IN PATIENTS WITH CERVICAL-CARCINOMA
Authors: BAAY MFD DUK JM BURGER MPM WALBOOMERS J TERSCHEGGET J GROENIER KH DEBRUIJN HWA STOLZ E HERBRINK P
Citation: Mfd. Baay et al., ANTIBODIES TO HUMAN PAPILLOMAVIRUS TYPE-16 E7 RELATED TO CLINICOPATHOLOGICAL DATA IN PATIENTS WITH CERVICAL-CARCINOMA, Journal of Clinical Pathology, 48(5), 1995, pp. 410-414
HIGHER LEVELS OF INTERLEUKIN-6 IN CYSTIC FLUIDS FROM PATIENTS WITH MALIGNANT VERSUS BENIGN OVARIAN-TUMORS CORRELATE WITH DECREASED HEMOGLOBIN LEVELS AND INCREASED PLATELET COUNTS
Authors: VANDERZEE AGJ DECUYPER EMJ LIMBURG PC DEBRUIJN HWA HOLLEMA H BIJZET J KRANS M DEVRIES EGE
Citation: Agj. Vanderzee et al., HIGHER LEVELS OF INTERLEUKIN-6 IN CYSTIC FLUIDS FROM PATIENTS WITH MALIGNANT VERSUS BENIGN OVARIAN-TUMORS CORRELATE WITH DECREASED HEMOGLOBIN LEVELS AND INCREASED PLATELET COUNTS, Cancer, 75(4), 1995, pp. 1004-1009
CA-125 IN SERUM AND TUMOR FROM PATIENTS WITH UTERINE SARCOMA
Authors: DUK JM BOUMA J BURGER GTN NAP M DEBRUIJN HWA
Citation: Jm. Duk et al., CA-125 IN SERUM AND TUMOR FROM PATIENTS WITH UTERINE SARCOMA, International journal of gynecological cancer, 4(3), 1994, pp. 156-160
CANCER-ASSOCIATED ANTIGEN CA-195 IN PATIENTS WITH MUCINOUS OVARIAN-TUMORS - A COMPARATIVE-ANALYSIS WITH CEA, TATI AND CA-125 IN SERUM SPECIMENS AND CYST FLUIDS
Authors: DEBRUIJN HWA TENHOOR KA BOONSTRA H MARRINK J KRANS M AALDERS JG
Citation: Hwa. Debruijn et al., CANCER-ASSOCIATED ANTIGEN CA-195 IN PATIENTS WITH MUCINOUS OVARIAN-TUMORS - A COMPARATIVE-ANALYSIS WITH CEA, TATI AND CA-125 IN SERUM SPECIMENS AND CYST FLUIDS, Tumor biology, 14(2), 1993, pp. 105-115
MATERNAL SERUM CA 125 LEVELS IN PREGNANCIES WITH CHROMOSOMALLY-NORMALAND CHROMOSOMALLY-ABNORMAL FETUSES
Authors: VANLITH JMM MANTINGH A DEBRUIJN HWA KLOOSTERMAN MD KANHAI HHH WOLF H EVERHARDT E CHRISTIAENS GCML
Citation: Jmm. Vanlith et al., MATERNAL SERUM CA 125 LEVELS IN PREGNANCIES WITH CHROMOSOMALLY-NORMALAND CHROMOSOMALLY-ABNORMAL FETUSES, Prenatal diagnosis, 13(12), 1993, pp. 1123-1131
Risultati: 1-21 |